:: Wachters.ca ::
new user  |  login  
user: anonymous
  Shopping Cart  
  Product Programs
  Personal Health Quiz
  Sea Vegetation
  Testimonials 1, 2, 3
  Testimonials - add
  Nutritional Glossary
  News Flash Links
  Weekly Special
  Policies & Procedures
  Contact us


Fact about The Wachters Blend of Sea Vegetation:

?Significant?: Vitamin E may slow functional decline in moderate Alzheimer patients

By Stephen Daniells+


"This new study demonstrates that scientists seeking to slam the door on vitamins, and new vitamin research, is the antithesis of what science is all about" - Duffy MacKay, ND, CRN
"This new study demonstrates that scientists seeking to slam the door on vitamins, and new vitamin research, is the antithesis of what science is all about" - Duffy MacKay, ND, CRN


Daily supplements of vitamin E (alpha tocopherol) may slow functional decline in people with mild to moderate Alzheimer’s disease, say results of a double-blind, placebo-controlled, parallel-group, randomized clinical trial.

Two thousand international units per day of vitamin E was associated with a delay in clinical progression of 19% per year, compared with placebo, according to findings published in JAMA .  

In addition, the study – one of the largest and longest treatment trials in patients with mild to moderate Alzheimer’s disease – supports the safety of vitamin E supplements.

“In contrast to the conclusion drawn from a 2005 meta-analysis of vitamin E, which showed that high-dose vitamin E (at least 400 IU/d) may increase the risk of all-cause mortality, we found no significant increase in mortality with vitamin E,” wrote the researchers. “The annual mortality rate was 7.3 percent in the alpha tocopherol group vs. 9.4 percent for the placebo group.”


Duffy MacKay, ND, vice president, scientific and regulatory affairs for the Council for Responsible Nutrition (CRN), welcomed the study’s findings, saying: “This study is significant as it presents strong data on the safety of vitamin E, at high doses, and dismisses previous questions raised about the safety of this essential nutrient. This new study demonstrates that scientists seeking to slam the door on vitamins, and new vitamin research, is the antithesis of what science is all about.

“In addition to confirming the safety of vitamin E, this study, one of the largest and longest treatment trials in patients with mild to moderate Alzheimer’s disease, found 2000 IU/daily of vitamin E compared with placebo resulted in slower functional decline in these patients. These results point to a powerful role of integrating proper nutrition into disease management, and provide hope for Alzheimer’s patients and their care givers.

"Because vitamin E is inexpensive, it is likely these benefits are cost-effective as alpha tocopherol improves functional outcomes and decreases caregiver burden.” - Dysken et al.

“However, the dietary supplement industry should be reminded that dietary supplements cannot be marketed or sold to consumers as a disease treatment, and we recommend that those suffering with Alzheimer’s disease rely on the advice of a trusted doctor as to the appropriate treatment plan. Self-dosing at the levels studied in this trial are not recommended. 

“It is commendable that aspects of this study ‘reflect the best in trials of Alzheimer disease therapy,’ as noted in an accompanying editorial, though we still encourage more research to further assess the role vitamin E plays in both the prevention and treatment of this very complicated disease.”


Study details

Researchers led by Maurice Dysken, MD, of the Minneapolis VA Health Care System, recruited 613 patients with mild to moderate Alzheimer’s to participate in their randomized clinical trial. The participants were randomly assigned to one of four groups: The first group received 2000 IU/d of vitamin E, the second group received 20 mg per day of memantine (an Alzheimer's disease medication), the third group received a combination of vitamin E and memantine, and the last group received placebo.

Data from the 561 participants who completed the study indicated that, over almost 2.5 years, the vitamin E group displayed slower functional decline equivalent to a clinically meaningful delay in progression of 6.2 months, compared with placebo. No benefits were observed in the memantine only or the vitamin E-memantine combination groups.

The study also supported the safety of vitamin E at a dose of 2000 IU per day.

On the other hand, significant increases in serious adverse events of “infections or infestations” were observed in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants), compared with placebo.

“In the current study, the placebo group lost approximately 3 units more on the [Alzheimer’s Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory] than the alpha-tocopherol group,” wrote the researchers.

“A loss of this magnitude could translate into either the complete loss of being able to dress or bath independently, for example, or losing independence on any 3 different [Activities of Daily Living]. Because vitamin E is inexpensive, it is likely these benefits are cost-effective as alpha tocopherol improves functional outcomes and decreases caregiver burden.”

Treatment vs preventions

In an accompanying editorial in JAMA, Denis Evans, MD, Martha Clare Morris, ScD, and Kumar Bharat Rajan, PhD, from Rush University Medical Center in Chicago, wrote: “Many features of the trial by Dysken et al reflect the best in trials of Alzheimer’s disease therapy, especially its size, duration, and separation from commercial motivation. However, as with almost all previous Alzheimer’s disease trials, the therapeutic effect seen was modest and more relevant to Alzheimer’s disease symptoms and consequences than to reversal of the disease process. The importance of treating patients with Alzheimer’s disease is clear, but finding the best balance between treatment and prevention efforts is challenging for this grim disease affecting millions of people from all developed countries.”

“Considering the difficulties inherent in trying to treat rather than prevent very high-prevalence diseases and the limitations thus far of the therapeutic efforts for people with Alzheimer’s disease, shifting to more emphasis on prevention seems warranted.”

Source: JAMA
2014, Volume 311, Number 1, Pages 33-44, doi:10.1001/jama.2013.282834
“Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease - The TEAM-AD VA Cooperative Randomized Trial”
Authors: M.W. Dysken, M. Sano, S. Asthana, et al.

Editorial: JAMA
2014, Volume 311, Number 1, Pages 29-30, doi: 10.1001/jama.2013.282835
“Vitamin E, Memantine, and Alzheimer Disease”
Authors: D.A. Evans, M.C. Morris, K.B. Rajan


Other items related to 'Research'
The long lasting benefits of supplements & the fascinating study that nobody is talking about
Multivitamins linked to younger ?biological age?
Review: B vitamins, the brain (& deficiencies)
Multivitamins can safely improve nutrient supply and overcome problems of inadequacy
Lutein and Zeaxanthin Benefit Young and Old Alike
8 Nutrients You May Be Lacking
Vitamin E is vital to building muscles and repairing cells
Psyllium Dietary Fiber Leads to Healthcare Cost Savings
Taking Prenatal Iron May Lower Your Child's Risk of Autism
Seaweed an effective alternative for iodine supplementation
Radiation report on the Wachters' Sea Vegetation Blend
Harvard?s large-scale randomized trial in men supports safety of vitamin C and E supplements
Chlorella supplements show cardiovascular benefits:
Meta-analysis: Vitamin C supplements may boost endothelial function
Abbott Nutrition study: Maternal lutein supplementation passes to child
4 Nutritional Supplements Every Man Needs
Nutrition researchers shoot holes in assertion that multivitamins are unnecessary
Zinc supplements may boost immune system in children
Iron supplements may boost female physical performance: Meta-analysis
Is dietary suplement use more prevalent than previously thought?
Resveratrol?s blood sugar management potential supported by meta-analysis, but are benefits limited
Vitamin D deficiency linked to compromised immune function
Daily multivitamin supplement may decrease cataract risk in men
Meta-analysis supports calcium?s weight management potential
CRN says 2015 dietary guidelines should include supplements
Vitamin D May Slow Multiple Sclerosis
Report: Who uses supplements?
Radiation Report - Wachters' Sea Blend
Magnesium may help people with heart problems to live longer
Telomeres, Aging, & Disease Prevention
Low dietary fibre intake may increase cardiovascular risk
CoQ10 may reverse effects of age-related mental decline
Resveratrol shows fat cell shrinking potential: Human data
Calcium, vitamin D opportunity grows as osteoporosis prevalence rises
Vitamin B shows stroke protection promise
?Game changing? economic report: Supplements could save billions of dollars in health care costs
8 Amazing Health Benefits of B Vitamins
7 Best Supplements for Weight Loss
Increased iron intake can reduce Parkinson?s risk
Vitamin D slashes blood pressure and CVD risk
More Vitamin D May Lower High Blood Pressure
CoQ10 can reduce heart failure by half
Mothers to be who do not take in enough iodine may put their children at risk of lower IQ
Top 10 benefits of Zinc
Spirulina can better manage blood sugar in diabetes patients
More vitamin D may mean faster recovery from muscle injury
Curcumin (in Wachters' products) may match exercise for heart health benefits
Echinacea extract may help prevent common cold: Study
Multivitamin supplements may cut cancer risk
Vitamin D supplements may benefit lupus
Silbinol is now in WPB
CoQ10 and vitamin B6 levels linked to lower artery disease risk
Congress recognizes 100th anniversary of the vitamin
Vitamin C may prevent bone loss
Multivitamins may boost memory for older men
Multivitamin shows brain boosting activity for elderly women
Study links vitamin D to heart disease and early death
Vitamin D Speeds Tuberculosis Recovery
Green tea may influence brain function & boost working memory
Turmeric compounds show blood sugar management activity
Vitamin D shows eye health benefits
Dietary magnesium may reduce the risk of colon cancer: Meta-analysis
Chlorella shows immune boosting potential
NPA: Consumer Reports supplements probe is insulting to consumers
Dietary antioxidants may help slash pancreatic cancer risk: EPIC data
CRN hails 100th anniversary of the vitamin, reminds consumers of benefits of supplements
Can You Take Too Much Vitamin D?
CoQ10 shows promise for Huntington's disease
Vitamin B6 Deficit Tied to Heart Disease Risk
WDNA contains Resveratrol
Multivitamin supplements boost brain function, say UK researchers
Multivitamins may boost memory
Supplements ? understanding the possibilities, accepting the limitations
Seaweed may reduce blood pressure in healthy kids
Tufts-Harvard study builds vitamin D's anti-diabetes potential
Vitamin E supplements may reduce lung disease risk
Vegans at Risk for Low Iodine
Vitamin D linked to lower eye risk in young women
Seaweed May Fight Radiation
Vegan diet requires omega-3 and B12 boost
Study unlocks lycopene?s heart health benefits
Magnesium supplements may reduce diabetes risk
Multivitamin use linked to fewer heart attacks for women
Vitamin B may help prevent Alzheimer?s
Resveratrol supplements could improve heart health
Selenium shows protective effect for bladder cancer
Calcium?s weight loss potential gets RCT support
Resveratrol may boost eye health
Psyllium Fiber and Postprandial Peptide Release
Science: The emerging ingredients for joint health
Multivitamins may help weight loss in obese women
Apple fibres may boost immune health
Vitamin insufficiency boosting age-related diseases
Soy may reduce diabetes risk in overweight women
Vitamin, minerals may reduce eczema risk in children
CoQ10 may protect against obesity problems: Study
Soy protein may reduce cholesterol levels for diabetics, too
Study identifies vitamin D?s benefits for diabetic heart health
Low vitamin D linked to female infections
Multivitamins & minerals help children's brain function: study
Seaweed works!

  back to channel  

channel: main Tuesday, January 7, 2014 - 4:12pm

new user |  login |  logout |  modify info |  webmail |
user: anonymous (access: )
This site powered by FallingApple.com SiteTools 3.0 & owned and operated by Triune-Being Research Organization Ltd.